Putative Tumor-Suppressive Function of Krüppel-Like Factor 4 in Primary Lung Carcinoma

  • Wenxian Hu
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Wayne L. Hofstetter
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Hong Li
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Yanbin Zhou
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Yong He
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Abujiang Pataer
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Li Wang
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Keping Xie
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Stephen G. Swisher
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
  • Bingliang Fang
    Authors' Affiliations: 1Sir Run Run Shaw Hospital, Zhejiang University, Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, People's Republic of China and Departments of 2Thoracic and Cardiovascular Surgery and 3Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

説明

<jats:title>Abstract</jats:title> <jats:p>Purpose: Krüppel-like factor 4 (KLF4) is a zinc-finger protein that plays important roles in stem cells and the development of gastric cancers. However, the role of KLF4 in primary lung cancer is unknown. The purpose of this study is to determine possible roles of KLF4 in lung cancer.</jats:p> <jats:p>Experimental Design: The KLF4 expression in primary lung cancer tissues and case-matched normal lung tissues were determined by protein and mRNA analyses. The effects of KLF4 on cell proliferation, clonogenic formation, and cell cycle progression were determined in cultured lung cancer cells or bronchial epithelial cells after enforced KLF4 overexpression or small interfering RNA knockdown. The in vivo antitumor activity of KLF4 was evaluated by using stably transfected lung cancer cells and by adenovector-mediated gene delivery. The effect of KLF4 in regulating p21 and cyclin D1 was also evaluated.</jats:p> <jats:p>Results: KLF4 protein and mRNA levels were dramatically decreased in most primary lung tumors compared with in case-matched normal lung tissues. Enforced expression of KLF4 resulted in marked inhibition of cell growth and clonogenic formation. The tumor-suppressive effect of KLF4 was associated with its role in up-regulating p21 and down-regulating cyclin D1, leading to cell cycle arrest at the G1-S checkpoint. Knockdown of KLF4 promoted cell growth in immortalized human bronchial epithelial cells. The enforced expression of KLF4 gene to lung cancer cells by ex vivo transfection or adenovector-mediated gene transfer suppressed tumor growth in vivo.</jats:p> <jats:p>Conclusions: Our results suggest that KLF4 plays an important role in suppressing the growth of lung carcinoma. (Clin Cancer Res 2009;15(18):5688–95)</jats:p>

収録刊行物

  • Clinical Cancer Research

    Clinical Cancer Research 15 (18), 5688-5695, 2009-09-14

    American Association for Cancer Research (AACR)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ